Skip to main content
Clinical Trials/NCT02714829
NCT02714829
Completed
N/A

Clinical Study to Evaluate Efficacy and Safety of "Inject BMP(Beta-TCP Containing rhBMP-2)" for Socket Preservation After Extraction of a Single-rooted Tooth: A Randomized, Outcomes Assessor-Blinded, Multi-center, Prospective Trial.

BioAlpha Inc.0 sites88 target enrollmentApril 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Alveolar Bone Preservation
Sponsor
BioAlpha Inc.
Enrollment
88
Primary Endpoint
compared the changed height and standard height by computed tomography.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This is a prospective, outcomes assessor-blinded, randomized study to evaluate the efficacy and safety of "Inject BMP(Injectable Ceramics Bone Graft Substitute Containing rhBMP-2)" for socket preservation after extraction of a single-rooted tooth, compared to ExcelOS-inject(Injectable Ceramics Bone Graft Substitute).

Detailed Description

Inject BMP is Injectable Ceramics Bone Graft Substitute(ExcelOS-inject) containing rhBMP-2. Recombinant human Bone morphogenetic protein 2 (rhBMP-2) stimulates the production of bone.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
April 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
BioAlpha Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Persons without periodontal disease

Exclusion Criteria

  • Women who are pregnant or plan to be pregnant within study period

Outcomes

Primary Outcomes

compared the changed height and standard height by computed tomography.

Time Frame: at 12 weeks after surgery

Similar Trials